Clinical Trial Update: A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating TAS2940 in locally advanced or metastatic solid tumors has been terminated. The trial enrolled patients with glioblastoma, non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Glioblastoma
• Non-small Cell Lung Cancer

Drugs mentioned

• TAS2940

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Solid Tumor, Glioblastoma | Phase 1 | Status: TERMINATED